Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 2/20 | 0.81 |
| ▸ | ACACA | Q13085 | 2/20 | 0.81 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | CRYAB | P02511 | 1/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.52 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 3/20 | 0.44 |
| ▸ | HMGCR | P04035 | 1/20 | 0.42 |
| ▸ | PTGES | O14684 | 3/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cycloartenol SCHEMBL12368108 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL13644393 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL13455189 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL560780 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL13420259 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL23754759 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL10034117 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL21754440 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL20778271 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL17057018 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200276211-A1 | COMPOUNDS FOR TREATING NEAR VISION DISORDERS | VIEWPOINT THERAPEUTICS INC (US) | 2020-09-03 | — | — | US | disclosed |
| EP-1930014-B1 | AGENT FOR AMELIORATION OF INSULIN RESISTANCE | MORINAGA MILK INDUSTRY CO LTD (JP) | 2017-03-01 | — | — | EP | disclosed |
| EP-2387406-B1 | POSTPRANDIAL HYPERGLYCEMIA-IMPROVING AGENT | KAO CORP (JP) | 2015-07-29 | — | — | EP | disclosed |
| US-20140193557-A1 | Method of Producing Processed Brown Rice | KAO CORPORATION (JP) | 2014-07-10 | — | — | US | disclosed |
| US-20140193557-A1 | Method of Producing Processed Brown Rice | KAO CORPORATION (JP) | 2014-07-10 | — | — | US | disclosed |
| US-8501721-B2 | Postprandial hyperglycemia-improving agent | KAO CORPORATION (JP) | 2013-08-06 | — | — | US | disclosed |
| US-8501721-B2 | Postprandial hyperglycemia-improving agent | KAO CORPORATION (JP) | 2013-08-06 | — | — | US | disclosed |
| US-8377894-B2 | Use of compounds based on cyclopropa(9,10)cyclopenta(a)phenanthrene ring such as 9,19-cyclolanostan-3-ol and 24-methylene-9,19-cyclolanostan-3-ol; Aloe vera extracts; solvent extraction process | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2013-02-19 | — | — | US | disclosed |
| US-8377894-B2 | Use of compounds based on cyclopropa(9,10)cyclopenta(a)phenanthrene ring such as 9,19-cyclolanostan-3-ol and 24-methylene-9,19-cyclolanostan-3-ol; Aloe vera extracts; solvent extraction process | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2013-02-19 | — | — | US | disclosed |
| US-20120128796-A1 | Extracts and Compounds from Ficus Benghalensis for Increasing Hair Growth and Decreasing Hair Loss | ALVI ARMANI GENOMICS INC. | 2012-05-24 | — | — | US | disclosed |
| US-20100035851-A1 | AGENT FOR IMPROVING INSULIN RESISTANCE | MORINAGA MILK INDUSTRY CO., LTD (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20100035851-A1 | AGENT FOR IMPROVING INSULIN RESISTANCE | MORINAGA MILK INDUSTRY CO., LTD (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20090054354-A1 | DRUG AND FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20090054354-A1 | DRUG AND FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1930014-A1 | AGENT FOR AMELIORATION OF INSULIN RESISTANCE | Morinaga Milk Industry Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
| EP-1882472-A1 | DRUGS, FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS | Morinaga Milk Industry Co., Ltd. (JP) | 2008-01-30 | — | — | EP | disclosed |
| US-20070196435-A1 | Drug and food or drink for improving hyperglycemia | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2007-08-23 | — | — | US | disclosed |
| US-20070196435-A1 | Drug and food or drink for improving hyperglycemia | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2007-08-23 | — | — | US | disclosed |
| EP-1795200-A1 | MEDICINE AND FOOD/BEVERAGE FOR AMELIORATING HYPERGLYCEMIA | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2007-06-13 | — | — | EP | disclosed |
| US-20070016982-A1 | Transgenic plants with increased titerpene saponin levels | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120128796-A1 | Extracts and Compounds from Ficus Benghalensis for Increasing Hair Growth and Decreasing Hair Loss | CAT, SHH, TYR | ACLY 888/4885ACACA 370/4885PTPN11 4454/4885 |
| US-20100035851-A1 | AGENT FOR IMPROVING INSULIN RESISTANCE | GPR119, IRS1, LIPE | ACLY 159/4885ACACA 290/4885PTPN11 1140/4885 |
| US-20200276211-A1 | COMPOUNDS FOR TREATING NEAR VISION DISORDERS | CRYAB, PDE6C, CRYAA | ACLY 1460/4885ACACA 71/4885PTPN11 4666/4885 |
| US-20090054354-A1 | DRUG AND FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS | GPR119, PNLIP, AMY2A | ACLY 1113/4885ACACA 449/4885PTPN11 3615/4885 |
| US-20070196435-A1 | Drug and food or drink for improving hyperglycemia | GPR119, SLC2A9, GCKR | ACLY 565/4885ACACA 305/4885PTPN11 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.